Helicobacter pylori infections – pipeline review, h2 2012


Published on

Aarkstore.com || Helicobacter Pylori Infections – Pipeline Review, H2 2012

Published in: Health & Medicine, Business
  • Be the first to comment

  • Be the first to like this

Helicobacter pylori infections – pipeline review, h2 2012

  1. 1. Aarkstore.com announces, The Latest market research report is available inits vast collection:Helicobacter Pylori Infections – Pipeline Review, H2 2012RSS link of Global Markets DirectSummaryGlobal Markets Direct’s, Helicobacter Pylori Infections - Pipeline Review, H2 2012,provides an overview of the Helicobacter Pylori Infections therapeutic pipeline. Thisreport provides information on the therapeutic development for Helicobacter PyloriInfections, complete with latest updates, and special features on late-stage anddiscontinued projects. It also reviews key players involved in the therapeuticdevelopment for Helicobacter Pylori Infections. Helicobacter Pylori Infections -Pipeline Review, H2 2012 is built using data and information sourced from GlobalMarkets Direct’s proprietary databases, Company/University websites, SEC filings,investor presentations and featured press releases from company/university sitesand industry-specific third party sources, put together by Global Markets Direct’steam.Note*: Certain sections in the report may be removed or altered based on theavailability and relevance of data for the indicated disease.Scope- A snapshot of the global therapeutic scenario for Helicobacter Pylori Infections.- A review of the Helicobacter Pylori Infections products under development bycompanies and universities/research institutes based on information derived fromcompany and industry-specific sources.- Coverage of products based on various stages of development ranging from
  2. 2. discovery till registration stages.- A feature on pipeline projects on the basis of monotherapy and combinedtherapeutics.Table of contents:List of Tables 5List of Figures 5Introduction 6Global Markets Direct Report Coverage 6Helicobacter Pylori Infections Overview 7Therapeutics Development 8An Overview of Pipeline Products for Helicobacter Pylori Infections 8Helicobacter Pylori Infections Therapeutics under Development by Companies 10Helicobacter Pylori Infections Therapeutics under Investigation byUniversities/Institutes 12Late Stage Products 13Comparative Analysis 13Mid Clinical Stage Products 14Comparative Analysis 14Early Clinical Stage Products 15Comparative Analysis 15Discovery and Pre-Clinical Stage Products 16Comparative Analysis 16Helicobacter Pylori Infections Therapeutics – Products under Development byCompanies 17Helicobacter Pylori Infections Therapeutics – Products under Investigation byUniversities/Institutes 18Companies Involved in Helicobacter Pylori Infections Therapeutics Development 19Sequella, Inc. 19Affinium Pharmaceuticals, Inc. 20Deva Holding A.S. 21MerLion Pharmaceuticals Pte Ltd 22EpiVax, Inc. 23Vecta Ltd. 24HeliCure AB 25
  3. 3. List of FiguresList of Tables are also include.For more related Reports Plz follow The link:Pipeline Review, H2 2012http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H22012&PubId=&pagenum=1Arthritis – Pipeline Review, H2 2012Ischemia – Pipeline Review, H2 2012Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) – PipelineReview, H2 2012Muscle Wasting Disorders – Pipeline Review, H2 2012Helicobacter Pylori Infections – Pipeline Review, H2 2012Chemotherapy Effects – Pipeline Review, H2 2012Follicular Lymphoma – Pipeline Review, H2 2012Sleep Disorders – Pipeline Review, H2 2012Neuroblastoma – Pipeline Review, H2 2012
  4. 4. Cytomegalovirus (HHV-5) Infections – Pipeline Review, H2 2012Search More Reports Related to This Category :Pharmaceuticals and Healthcarehttp://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals andHealthcare&PubId=&pagenum=1For More details Plz do contact :Aarkstore EnterpriseLavanyaPhone:08149852585Email: enquiry@aarkstore.com